InVivo Therapeutics Corp., which brought in a $10.5 million investment as part of a reverse merger on Wednesday, has repaid a $567,930 loan from the Massachusetts Life Sciences Center, according to life sciences center president and CEO Susan Windham-Bannister.

InVivo, which is developing a treatment for spinal cord injuries, had received the loan from the life sciences center’s Accelerator Program in May 2009.

SOURCE